Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov
Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby

LOBBYING REGISTRATION

Lobbying Disclosure Act of 1995 (Section 4)

Check One: New Registrant New Client for Existing Registrant Amendment

1. Effective Date of Registration
07/15/2014
2. House Identification
 42677
Senate Identification
 401103351

REGISTRANT Organization/Lobbying Firm Self Employed Individual

3. Registrant Organization
CapitalHill Advisory
Address
1717 Pennsylvania Ave NW Suite 1025
Address2
City
Washington
State
DC
Zip
20006
Country
USA

4. Principal place of business (if different than line 3)

City
​Sydney
State
Zip
​2000
Country
​AUS
5. Contact name and telephone number International Number
Contact
​Ms. Cathy Duncan
Telephone
​0292230311
E-mail
​cd@capitalhilladvisory.com.au
6. General description of registrant’s business or activities
​Corporate and Government Relations Consulting

CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self

7. Client name
​Pfizer Australia Pty Ltd
Address
​38-42 Wharf Ave
City
​West Ryde NSW
State
Zip
​2114
Country
​AUS
8. Principal place of business (if different than line 7)
City
State
Zip
Country
9. General description of client’s business or activities
​Pharmaceutical Company

LOBBYISTS

10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.

Name Covered Official Position (if applicable)
First
Last
Suffix
​Nick ​Campbell ​Mr

LOBBYING ISSUES

11. General lobbying issue areas (Select all applicable codes).

​ECN
​GOV
​PHA
​TAX

12. Specific lobbying issues (current and anticipated)

Privileged & Confidential The Australian Government's policy of initiating court proceedings to recovered damages from innovative pharmaceutical companies in cases where patents covering pharmaceutical benefits scheme (PBS)- listed medicines have been found invalid following an initial grant of an interlocutory injunction which delayed the launch of generic products


AFFILIATED ORGANIZATIONS

13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?

No --> Go to line 14. Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14.

Internet Address:
Name Address Principal Place of Business
Street
City State/Province Zip Code Country
City
State
Country
City
State
Country
City
State
Country

FOREIGN ENTITIES

14. Is there any foreign entity

a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or

b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or

c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?

No --> Sign and date the registration. Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration.

Address Ownership
Name Street Principal place of business Amount of contribution
City State/Province Country
(city and state or country) for lobbying activities

​235 East 42nd St
City
​Pfizer Int.
​New York
​NY
​USA
State
Country
​0.00
​100
%
City
State
Country
%

Signature
Digitally Signed By: Cathy Duncan, Practice Manager
Date
09/01/2014